The lecanemab open-label extension trial for AD showed no new safety signals, but the placebo roll-over group failed to show the gains seen in the experimental arm.
BEVERLY — When Amy Carnevale learned she had made the freshman basketball cheerleading team at Beverly High School, she turned to her father and said, “Dad, I can’t wait to
New research, a potential state ballot measure and pending decisions from the FDA are putting psychedelics are on a path that could lead them to become an integral part of mental health care in Massachusetts.